Trial
NCT00258440
Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
OHSU Knight Cancer Institute
Collaborators
Ortho Biotech, Inc.
Condition
Anemia
Intervention
Weekly procrit dosing
Why stopped
Sponsor discontinued funding of the study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-09